Sartorius AG ST buy WatchMen
Summary
This prediction is currently active. The BUY prediction by WatchMen for Sartorius AG ST is performing very badly with a performance of -31.60%. Dividends of €0.74 are taken into consideration when calculating the performance. This prediction currently runs until 22.03.25. The prediction end date can be changed by WatchMen at any time. WatchMen has 50% into this predictionSartorius is a German-based biotech and laboratory equipment company that is listed on the Frankfurt Stock Exchange under the symbol SARTF. The company provides products and services for the pharmaceutical, biotech, and food industries, including laboratory instruments, consumables, and services. Sartorius has a global presence with operations in Europe, Asia, and the Americas, and has a strong reputation for innovation, quality, and reliability. The company's stock has performed well in recent years, reflecting its solid financial results and growth prospects in the life sciences industry.
Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sartorius AG ST | 5.472% | 5.472% |
iShares Core DAX® | 1.164% | 1.549% |
iShares Nasdaq 100 | 0.118% | 0.969% |
iShares Nikkei 225® | 1.124% | -1.120% |
iShares S&P 500 | 0.479% | 1.068% |
Comments by WatchMen for this prediction
In the thread Sartorius AG diskutieren